脑肿瘤切除期间及术后新发癫痫发作:风险评估分析
该回顾性病例对照研究纳入2004年1月1日至2015年6月31日在本机构接受肿瘤切除或活检的成人,排除术前癫痫、后颅窝肿瘤、垂体瘤及鞍旁肿瘤患者。1693例中549例(32.4%)术前无癫痫,其中25例(4.6%)发生围手术期癫痫(组1),按年龄匹配132例对照(组2)。浸润性胶质瘤、硬膜内肿瘤位置、术中皮层刺激及非全切除与围手术期癫痫相关。作者认为多数术前无癫痫的脑肿瘤患者不获益于围手术期癫痫预防,但高危患者应考虑预防。
要点
- 术前无癫痫的脑肿瘤患者中围手术期癫痫发生率为4.6%(25/549)。
- 浸润性胶质瘤、硬膜内肿瘤位置、术中皮层刺激及非全切除与围手术期癫痫相关。
- 作者认为多数术前无癫痫患者不获益于预防,但高危患者应考虑预防。
核心结论
- 多数术前无癫痫的脑肿瘤患者不获益于围手术期癫痫预防,但高危患者应考虑预防。
研究设计与样本
- 回顾性病例对照研究,纳入2004年1月1日至2015年6月31日在本机构接受肿瘤切除或活检的成人。
- 排除术前癫痫、后颅窝肿瘤、垂体瘤及鞍旁肿瘤患者。
- 1693例中549例(32.4%)术前无癫痫,其中25例(4.6%)发生围手术期癫痫(组1)。
- 按年龄(±0岁)匹配132例对照(组2),比例约1:5。
主要发现
- 组织学亚型(浸润性胶质瘤 vs 脑膜瘤 vs 其他,p=0.041)与围手术期癫痫相关。
- 硬膜内肿瘤位置(p<0.001)与围手术期癫痫相关。
- 术中皮层刺激(p=0.004)与围手术期癫痫相关。
- 切除范围(非全切除,p=0.002)与围手术期癫痫相关。
- 两组在年龄、性别、种族、关系状态及就诊时神经功能缺损方面无差异。
关键数值与推荐
- 围手术期癫痫定义为术中及术后30天内发生的癫痫。
- 术前无癫痫患者中围手术期癫痫发生率为4.6%(25/549)。
临床怎么用
- 作者认为多数术前无癫痫的脑肿瘤患者不获益于围手术期癫痫预防。
- 作者认为对于幕上硬膜内肿瘤、接受术中皮层刺激及可能次全切除的高危患者,应考虑围手术期癫痫预防。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE Prophylactic use of antiepileptic drugs (AEDs) in seizure-naïve brain tumor patients remains a topic of debate. This study aimed to characterize a subset of patients at highest risk for new-onset perioperative seizures (i.e., intraoperative and postoperative seizures occurring within 30 days of surgery) who may benefit from prophylactic AEDs. METHODS The authors conducted a retrospective case-control study of all adults who had undergone tumor resection or biopsy at the authors' institution between January 1, 2004, and June 31, 2015. All patients with a history of preoperative seizures, posterior fossa tumors, pituitary tumors, and parasellar tumors were excluded. A control group was matched to the seizure patients according to age (± 0 years). Demographic data, clinical status, operative data, and postoperative course data were collected and analyzed. RESULTS Among 1693 patients who underwent tumor resection or biopsy, 549 (32.4%) had never had a preoperative seizure. Of these 549 patients, 25 (4.6%) suffered a perioperative seizure (Group 1). A total of 524 patients (95.4%) who remained seizure free were matched to Group 1 according to age (± 0 years), resulting in 132 control patients (Group 2), at an approximate ratio of 1:5. There were no differences between the patient groups in terms of age, sex, race, relationship status, and neurological deficits on presentation. Histological subtype (infiltrating glioma vs meningioma vs other, p = 0.041), intradural tumor location (p < 0.001), intraoperative cortical stimulation (p = 0.004), and extent of resection (less than gross total, p = 0.002) were associated with the occurrence of perioperative seizures. CONCLUSIONS While most seizure-naïve brain tumor patients do not benefit from perioperative seizure prophylaxis, such treatment should be considered in high-risk patients with supratentorial intradural tumors, in patients undergoing intraoperative cortical stimulation, and in patients in whom subtotal resection is likely.
引用
- Oushy S, Sillau SH, Ney DE, et al. New-onset seizure during and after brain tumor excision: a risk assessment analysis. J Neurosurg. 2017. PMID: 28753117. doi:10.3171/2017.2.JNS162315
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。